Cargando…

Deep White Matter in Huntington's Disease

White matter (WM) abnormalities have already been shown in presymptomatic (Pre-HD) and symptomatic HD subjects using Magnetic Resonance Imaging (MRI). In the present study, we examined the microstructure of the long-range large deep WM tracts by applying two different MRI approaches: Diffusion Tenso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, Owen, Squitieri, Ferdinando, Sanchez-Castaneda, Cristina, Elifani, Francesca, Caltagirone, Carlo, Sabatini, Umberto, Di Paola, Margherita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207674/ https://www.ncbi.nlm.nih.gov/pubmed/25340651 http://dx.doi.org/10.1371/journal.pone.0109676

Ejemplares similares

Tractography of the Corpus Callosum in Huntington’s Disease
por: Phillips, Owen, et al.
Publicado: (2013)

Major Superficial White Matter Abnormalities in Huntington's Disease
por: Phillips, Owen R., et al.
Publicado: (2016)

Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease
por: Di Pardo, Alba, et al.
Publicado: (2013)

Linking white matter and deep gray matter alterations in premanifest Huntington disease
por: Faria, Andreia V., et al.
Publicado: (2016)

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?
por: Migliore, Simone, et al.
Publicado: (2019)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Characterizing White Matter in Huntington's Disease
por: Gregory, Sarah, et al.
Publicado: (2019)

“Spazio Huntington”: Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG Repeats
por: Graziola, Federica, et al.
Publicado: (2022)

Neuropsychiatry and White Matter Microstructure in Huntington’s Disease
por: Gregory, Sarah, et al.
Publicado: (2015)

Insights into White Matter Defect in Huntington’s Disease
por: Sun, Yize, et al.
Publicado: (2022)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
por: D’Aurizio, Giulia, et al.
Publicado: (2019)

Sleep Quality and Related Clinical Manifestations in Huntington Disease
por: Maffi, Sabrina, et al.
Publicado: (2022)

DNA instability in replicating Huntington's disease lymphoblasts
por: Cannella, Milena, et al.
Publicado: (2009)

Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington’s Disease
por: Pellegrini, Miguel, et al.
Publicado: (2022)

Multiparametric characterization of white matter alterations in early stage Huntington disease
por: Adanyeguh, Isaac M., et al.
Publicado: (2021)

Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease
por: Carrizzo, Albino, et al.
Publicado: (2014)

Mitochondrial Respiration Changes in R6/2 Huntington’s Disease Model Mice during Aging in a Brain Region Specific Manner
por: Burtscher, Johannes, et al.
Publicado: (2020)

White matter predicts functional connectivity in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

In vivo characterization of white matter pathology in premanifest huntington's disease
por: Zhang, Jiaying, et al.
Publicado: (2018)

A Critical Review of White Matter Changes in Huntington’s Disease
por: Casella, Chiara, et al.
Publicado: (2020)

Aripiprazole in the treatment of Huntington’s disease: a case series
por: Ciammola, Andrea, et al.
Publicado: (2009)

Current Pharmacological Management in Juvenile Huntington’s Disease
por: Robertson, Lisa, et al.
Publicado: (2012)

Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation
por: Cariulo, Cristina, et al.
Publicado: (2017)

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Natural biological variation of white matter microstructure is accentuated in Huntington's disease
por: Gregory, Sarah, et al.
Publicado: (2018)

Early white matter pathology in the fornix of the limbic system in Huntington disease
por: Gabery, Sanaz, et al.
Publicado: (2021)

Progressive alterations in white matter microstructure across the timecourse of Huntington's disease
por: Estevez‐Fraga, Carlos, et al.
Publicado: (2023)

Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task
por: Hünefeldt, Thomas, et al.
Publicado: (2020)

Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington’s disease
por: Hu, Beini, et al.
Publicado: (2023)

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease
por: De Paepe, Audrey E., et al.
Publicado: (2019)

Developmental Whole Brain White Matter Alterations in Transgenic Huntington’s Disease Monkey
por: Meng, Yuguang, et al.
Publicado: (2017)

Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
por: Zeun, Paul, et al.
Publicado: (2022)

Polyglutamine expansion affects huntingtin conformation in multiple Huntington’s disease models
por: Daldin, Manuel, et al.
Publicado: (2017)

White matter hyperintensities segmentation: a new semi-automated method
por: Iorio, Mariangela, et al.
Publicado: (2013)

Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2017)

Fixel-Based Analysis Effectively Identifies White Matter Tract Degeneration in Huntington’s Disease
por: Oh, Sher Li, et al.
Publicado: (2021)

Cortical Grey Matter and Subcortical White Matter Brain Microstructural Changes in Schizophrenia Are Localised and Age Independent: A Case-Control Diffusion Tensor Imaging Study
por: Chiapponi, Chiara, et al.
Publicado: (2013)

Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross‐sectional study
por: Migliore, Simone, et al.
Publicado: (2021)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Brain Regions Showing White Matter Loss in Huntington’s Disease Are Enriched for Synaptic and Metabolic Genes
por: McColgan, Peter, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_piv5pu1nve99o9a39j4fh4ilts